Back

What is the latest randomized evidence in TAVI field.

3 September 2019 (14:30 - 14:53)
Organised by:
Congress Presentation Part of: Severe symptomatic aortic valve stenosis – TAVI the first treatment choice for all? Noncoronary Cardiac Intervention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Andreas Baumbach

St Bartholomews and Queen Mary University, London (United Kingdom of Great Britain & Northern Ireland)

2 More presentations in this session

Presentation thumbnail
Is durability still an issue?
Professor E. Durand (Rouen, FR)
Slides Video
Presentation thumbnail
NOAC, Vitamin K Antagonists, dual or single antiplatelet therapy after TAVI?
Professor J. Mehilli (Landshut, DE)
Slides Video

Access the full session

Session thumbnail
Severe symptomatic aortic valve stenosis – TAVI the first treatment choice for all?

The Event

Event poster

ESC Congress 2019

3 September 2019 14:30 CET
You may be interested in
thumbnail
Congress Session
Interventional treatment of mitral and tricuspid valve disease
thumbnail
Congress Session
Complex device therapy
thumbnail
Congress Session
Lead extraction

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources